TIDM3DD

3D Diagnostic Imaging PLC

16 May 2011

 
 For Immediate Release   16 May 2011

3D DIAGNOSTIC IMAGING PLC

("3D" or "the Company")

CarieScan expands its distribution network in the UK

DenPro to showcase the CarieScan PRO at the BDA Conference on 19 - 21 MAY 2011

3D is pleased to announce that its subsidiary CarieScan Limited ("CarieScan"), the producer of a handheld device for the early detection and monitoring of tooth decay, has entered into a non-exclusive UK distribution agreement with DenPro, for the CarieScan PRO.

This follows the signing of recent distribution agreements covering China, India, Germany, Austria and Switzerland earlier this year, and is in addition to the Company's existing distribution agreement covering North America.

DenPro supports a group of well-established regional dental distributors who collectively have 18 representatives supporting dental practices throughout the UK.

The CarieScan PRO will be showcased by DenPro at the British Dental Association (BDA) Conference, one of the UK's largest dental conferences, in Manchester on 19 - 21 May 2011.

Commenting on this agreement, Graham Lay, Chief Executive Officer of 3D Diagnostic Imaging, said:

"The distribution of the CarieScan PRO by DenPro is a welcome extension of our reach in the UK and and a continuation of our objective of strengthening our distribution channels both in the UK and overseas. We look forward to working with DenPro who will showcase the device at the BDA conference later this month."

Andrew Haughton, Director of Denpro commented:

"DenPro is delighted to introduce CarieScan PRO into its product offering. Early and accurate detection of dental disease is a fundamental requirement of modern dentistry as we move towards a more preventive orientation of dental care. CarieScan PRO enables the dentist to achieve these goals. It is a concept which fits soundly within the ethos of DenPro: to provide equipment and materials of the very best quality and value to its customers, enabling them to offer their patients the highest standards of treatment."

For further information please contact:

 
 3D Diagnostic Imaging Plc    +44 (0) 1624 679000 
 Graham Lay, CEO 
 Oliver Cooke, FD 
 
 finnCap                      NOMAD & Broker 
 Geoff Nash                   +44 (0) 20 7600 1658 
 Henrik Persson 
 Stephen Norcros (broking) 
 
 Buchanan Communications      +44 (0) 131 226 4427 
 Diane Stewart                +44 (0) 207 466 5000 
 Carrie Clement

Notes to Editors:

3D owns the protected rights to a technology platform with a number of significant potential commercial applications. Its first product to market is the CarieScan PROtm.

The CarieScan PROtm measures the presence of tooth decay earlier and more accurately than any other device on the market and is more than 90% accurate in detecting both sound and carious teeth, well ahead of other methods. It detects "hidden" decay, providing dental practitioners with the opportunity to arrest or even reverse decay, driving the trend towards preventative dental care.

The lightweight CarieScan PROtm detection monitor not only offers best-in-class performance for decay detection but also allows easy monitoring of the effect of treatment regimes to show decay advancement or regression, thus enabling dentists to tailor treatment to the needs of the patient at a low cost. The CarieScan PROtm consists of a hand piece and a disposable sensor which is held against the tooth being examined in a process which takes approximately with the result displayed on the CarieScan PROtm.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRADKPDPCBKDAPD

3D Diagnostic (LSE:3DD)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more 3D Diagnostic Charts.
3D Diagnostic (LSE:3DD)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more 3D Diagnostic Charts.